Hing C. Wong
CIK: 0001866258
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
HCW Biologics Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- May 22, 2026HCWB
HCW Biologics Inc.
Purchase(P)Direct113.9K shares at avg. $1.41$160K - May 16, 2025HCWB
HCW Biologics Inc.
Purchase(P)Direct8.1K shares at avg. $7.45$60K - May 8, 2025HCWB
HCW Biologics Inc.
Purchase(P)Direct92.5K shares at avg. $26.00$2.4M - May 7, 2025HCWB
HCW Biologics Inc.
Purchase(P)DirectCommon Stock Purchase Warrant
46.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 22, 2026 | HCWB HCW Biologics Inc. | Purchase(P) | 113,879 | $1.41 | $160,000 | Direct |
| May 16, 2025 | HCWB HCW Biologics Inc. | Purchase(P) | 8,054 | $7.45 | $60,002 | Direct |
| May 8, 2025 | HCWB HCW Biologics Inc. | Purchase(P) | 92,500 | $26.00 | $2,405,000 | Direct |
| May 7, 2025 | HCWB HCW Biologics Inc. | Purchase(P) Common Stock Purchase Warrant | 46,250 | - | - | Direct |
1-4 of 4 transactions
About Wong Hing C
Wong Hing C (SEC CIK 0001866258) files insider reports with the SEC as Chief Executive Officer of HCW Biologics Inc. (HCWB).
Signal8 holds 3 ownership filings by Wong Hing C, all Form 4s, filed between May 9, 2025 and May 27, 2026. Those filings report 4 transactions, from May 7, 2025 to May 22, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Wong Hing C's filings is in MIRAMAR,, FL.
Recent filings by Wong Hing C
Other insiders filing for HCW Biologics Inc. (HCWB)
- GARRETT SCOTT T, Director
- Byam Rebecca, Chief Financial Officer
- Winer Gary M, Director
- Flowers Lee, SVP of Business Development
- Greene Rick S., Director